Morgan Stanley’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $504M | Buy |
|
|||||
|
2025
Q1 | $363M | Buy |
|
|||||
|
2024
Q4 | $409M | Buy |
|
|||||
|
2024
Q3 | $342M | Buy |
|
|||||
|
2024
Q2 | $310M | Sell |
|
|||||
|
2024
Q1 | $376M | Sell |
|
|||||
|
2023
Q4 | $492M | Buy |
|
|||||
|
2023
Q3 | $226M | Buy |
|
|||||
|
2023
Q2 | $131M | Buy |
|
|||||
|
2023
Q1 | $23.4M | Buy |
|
|||||
|
2022
Q4 | $2.75M | Buy |
|
|||||
|
2022
Q3 | $132K | Buy |
|
|||||
|
2022
Q2 | $106K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $7K | Buy |
|